Loading…
This event has ended. Create your own event on Sched.
This virtual series will start at 11AM EDT each day and features four themes - Operational Excellence, Marketing, Regulatory Compliance, and Legal Considerations. Attend the sessions that fit your needs, get your questions answered, and further the conversations important to you.

Be sure to REGISTER TODAY and secure your seat at this free virtual event!

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

General Session [clear filter]
Monday, August 10
 

10:00am EDT

10:05am EDT

Keynote: The Future Value of AI
  • Ideas to consider         
  • Questions to ask         
  • Architectural approaches         
  • Buy-in from the board         
  • Connecting the dots inside a company         
  • Real-world applications

Speakers
avatar for Bob Evans

Bob Evans

Founder & CEO, Evans Strategic Communications LLC, Cloud Wars Media LLC
Bob Evans is one of the world’s leading analysts of the technology industry and the global phenomenon of digital transformation. In 2012, he was recruited by Oracle founder Larry Ellison to be the company’s first chief communications officer, and he left there after 5 years to... Read More →


Monday August 10, 2020 10:05am - 10:30am EDT
TBA
 
Tuesday, August 11
 

10:00am EDT

10:05am EDT

Keynote: Plug and Play AI - Embedding Cutting Edge AI into Business Processes and Applications
Speakers
avatar for Bindu Reddy

Bindu Reddy

CEO and Co-Founder, Abacus.AI
​​​​Bindu Reddy is the CEO and Co-Founder of Abacus.AI. Before starting Abacus.AI, she was the General Manager for AI Verticals at AWS, AI. Her organization created and launched Amazon Personalize and Amazon Forecast, the first of their kind AI services that enable organizations... Read More →


Tuesday August 11, 2020 10:05am - 10:30am EDT
TBA
 
Wednesday, August 12
 

10:00am EDT

10:05am EDT

Keynote: AI-Celerating R&D - Value and Impact in a Time of Convergence
While investment across the biopharma industry in R&D has been consistent or increased over the past 15 years, productivity has remained largely unchanged. Even with the projection that knowledge of medicine is doubling every 18 months, there must be better ways to understand biology and pathobiology and better ways to treat disease and manage healthcare.

Convergence, the result of the sharing of methods and ideas across multiple fields and industries, is the integration of insights and approaches from historically distinct scientific and technological disciplines. At AbbVie, our Convergence initiative seeks to create integrated R&D data and analytics capabilities that power data-driven insights – leading to better, faster decisions and therapies for patients. We are building a foundation for change, and setting out to double R&D productivity.

While hype alarms go off any time someone mentions Artificial Intelligence or ‘AI’, there are boundless opportunities to redefine AI – to engage it as the power of Automation and Insights – and drive value and impact in R&D. Tune in to this keynote to learn how AbbVie data scientists are helping our researchers scale the ladder of inference, how they are helping build foundations for growth and new capabilities, and how they are freeing up our people to perform higher value tasks. Ultimately guided by human empathy and experience, this will drive an increased ability to make a remarkable impact in the lives of patients.

Speakers
avatar for Brian Martin

Brian Martin

Head of AI, Research Fellow, AbbVie
Brian joined AbbVie in 2018 as head of a newly formed AI team, focused on accelerating, scaling, and amplifying the work of AbbVie’s R&D community using technologies like machine learning, deep learning, and cognitive computing. Prior to joining AbbVie, Brian spent five years consulting... Read More →


Wednesday August 12, 2020 10:05am - 10:30am EDT
TBA